- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00827827
Strength Training for Skeletal Muscle Adaptation After Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study investigates the hypothesis that a novel, high intensity, high repetition ST program will improve abnormalities in paretic and non-paretic leg muscle volume and composition compared to an attention-matched control regimen of supervised stretching over a 3-month intervention period in those disabled by stroke. The investigators further hypothesize that ST-induced skeletal muscle adaptation will translate into improved insulin sensitivity, strength, and function in this population. The specific objectives are to: 1) Determine the effects ST compared to a control intervention on paretic and non-paretic abnormalities in skeletal muscle volume, intramuscular fat, muscle fiber distribution, muscle capillary density, and muscle inflammation in chronically disabled stroke survivors. 2) Determine the effects ST compared to a control intervention on insulin sensitivity in stroke survivors, and whether structural and cellular skeletal muscle mechanisms contribute to improvements in insulin sensitivity after ST. 3) Determine the effects ST compared to a control intervention on physical function (strength, walking speed and balance) in stroke survivors, and whether structural skeletal muscle mechanisms predict ST-induced functional improvement.
The project design consists of 4 phases over 5 months for stroke participants enrolled in either of the two intervention arms (ST vs. CONTROL). During phase 1 the investigators will screen and consent chronic stroke patients with residual gait deficits. Phase 2 (3 weeks) will consist of baseline testing that includes dual energy X-ray absorptiometry (DEXA) scanning, bilateral CT scanning of the legs, bilateral vastus lateralis muscle biopsies, strength testing, timed walks, balance measurements, oral glucose tolerance testing, and hyperglycemic clamp testing. Following completion of baseline testing, volunteers are to be randomized to ST or the CONTROL group. Phase 3 (Intervention Phase, 3 months) will begin with 2 sessions of acclimatization for those assigned to the ST group. ST will then be progressed to 2 sets of 20 repetitions on each leg on each machine (Keiser Leg Press, Leg Extension, Leg Curl) with gradual increases in resistance over 3 months. Those in the CONTROL group will receive equal exposure to health care personnel in the Baltimore VA Exercise facility, performing a full battery of upper and lower body passive and active stretching exercises at each intervention session. In Phase 4 all baseline testing and laboratory analyses will be repeated.
Developing evidence-based therapies to combat skeletal muscle deterioration is highly relevant for chronically disabled stoke survivors. There is mounting evidence that current models of post-stroke rehabilitation are not optimal for maximizing recovery of muscle mass, strength, and metabolic health. The proposed research will develop new insight into the utility of progressive ST for reversing detrimental changes to gross muscle composition, muscle molecular phenotype, muscle inflammation, and muscle capillarization. Changes to any or all of these muscle parameters should have measurable impact on both whole body insulin sensitivity and function. Collectively, the results from this trial may change the current standard of care for stroke survivors by providing evidenced reasons for augmenting physical therapists' treatments, allowing more intense and diverse therapy sessions for maintenance of skeletal muscle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Stroke greater than 6 months prior with residual hemiparetic gait in women or men aged 40-85 years
- Completion of all regular post-stroke physical therapy
- Adequate language and neurocognitive function to participate in testing and training and to give adequate informed consent
Exclusion Criteria:
- Alcohol consumption greater than 3 oz. liquor, or 3 x 4 oz glasses of wine, or 3 x 12 oz. beers per day, by self-report
clinical history of:
- unstable angina
- recent (less than 3 months) myocardial infarction or congestive heart failure (NYHA category II)
- hemodynamically significant valvular dysfunction
- peripheral arterial occlusive disease (PAOD) with claudication
- major orthopedic, chronic pain, or non-stroke neuromuscular disorders restricting exercise
- pulmonary or renal failure
- poorly controlled hypertension (greater than 190/110)
- recent hospitalization for severe disease or surgery
- severe or global receptive aphasia which confounds reliable testing and training
- Allergy to lidocaine
- Known muscle disorder
- Taking Coumadin or Lovenox (contraindication for muscle biopsies)
- Dementia
- Untreated major depression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1
Participants in this group undergo lower-extremity strength training on three pneumatic resistance machines (Keiser Leg Press, Keiser Leg Extension, and Keiser Leg Curl).
Training sessions happen 3 times per week (M,W,F) and last approximately 45 minutes to 1 hour.
Participants in this group exercise each limb individually to account for the large discrepancies in strength between legs in stroke survivors.
|
3x per week lower-extremity ST lasting approximately 45 minutes to 1 hour.
|
|
Active Comparator: Arm 2
Participants in this group receive equal exposure to study staff compared with the experimental ST group (approximately 45 minutes to 1 hour 3 times per week).
Exercise sessions for this group involve a full battery of active and passive...upper and lower body...stretching and range of motion exercises performed on raised padded tables.
|
3x per week upper and lower body stretching mixed with active and passive range of motion exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)
Time Frame: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)
Time Frame: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 1-RM Muscle Strength (Leg Extension, Paretic Side)
Time Frame: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in 1-RM Muscle Strength (Leg Extension, Non-Paretic Side)
Time Frame: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Leg Muscle Endurance (Paretic Side)
Time Frame: Baseline, 3 Months
|
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
|
Baseline, 3 Months
|
|
Change in Leg Muscle Endurance (Non-Paretic Side)
Time Frame: Baseline, 3 months
|
Tests how training impacts the total number of submaximal repetitions a participant can perform according to standardized cadence (at the same absolute level of resistance, pre and post).
|
Baseline, 3 months
|
|
Change in 6-minute Walk Distance
Time Frame: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in 10 Meter Walking Speed (Self-Selected)
Time Frame: Baseline, 3 months
|
Baseline, 3 months
|
|
|
Change in 10 Meter Walking Speed (Fastest)
Time Frame: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Peak Aerobic Capacity (VO2 Peak)
Time Frame: Baseline, 3 Months
|
Baseline, 3 Months
|
|
|
Change in Berg Balance Scale
Time Frame: Baseline, 3 months
|
This measure is a 14 item scale, with each item scored (0-4) and summed for a maximum score of 56 points.
Range is 0-56 and higher values represent a better outcome.
|
Baseline, 3 months
|
|
Change in Paretic Limb Step Time (Self-Selected)
Time Frame: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Paretic Limb Step Time (Fastest)
Time Frame: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Non-Paretic Limb Step Time (Self-Selected)
Time Frame: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Non-Paretic Limb Step Time (Fastest)
Time Frame: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Paretic Limb Step Length (Self-Selected)
Time Frame: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Paretic Limb Step Length (Fastest)
Time Frame: Baseline, 3 months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 months
|
|
Change in Non-Paretic Limb Step Length (Self-Selected)
Time Frame: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
|
Change in Non-Paretic Limb Step Length (Fastest)
Time Frame: Baseline, 3 Months
|
This and other measures come from Instrumented Walkway (Gait Rite)
|
Baseline, 3 Months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Ivey FM, Prior SJ, Hafer-Macko CE, Katzel LI, Macko RF, Ryan AS. Strength Training for Skeletal Muscle Endurance after Stroke. J Stroke Cerebrovasc Dis. 2017 Apr;26(4):787-794. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.018. Epub 2016 Nov 16.
- Ivey FM, Ryan AS. Resistive training improves insulin sensitivity after stroke. J Stroke Cerebrovasc Dis. 2014 Feb;23(2):225-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.014. Epub 2013 Jan 22.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6737-R
- H30631 (Other Identifier: Baltimore VAMC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Exercise- Strength Training
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)CompletedDiabetic | CardiovascularCanada
-
University of ZululandCompletedOsteoarthritisUnited States
-
University of VigoNot yet recruitingBreast Cancer | Breast Cancer Survivor | Breast Cancer Patients | Breast Cancer - FemaleSpain
-
Wake Forest University Health SciencesU.S. Army Medical Research and Development CommandCompletedOveruse InjuryUnited States
-
LHL HelseUniversity of Oslo; Hasselt UniversityCompleted
-
Riphah International UniversityRecruitingPatellofemoral Pain Syndrome | Resistance Training | Kinesiophobia | SprintersPakistan
-
University of MinnesotaCompletedObesity | Physical InactivityUnited States
-
University of Missouri-ColumbiaCompletedCardiovascular Diseases | Quality of Life | Aging | Memory LossUnited States
-
Norwegian University of Science and TechnologyCompleted
-
Asan Medical CenterRecruitingBreast NeoplasmsKorea, Republic of